Thomas C.

Crawford, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals,

Inc(SIGNIFICANT)

View Full Disclosure

Latest in
Ventricular Arrhythmic Complications in Apical Ballooning Takotsubo Syndrome

Dec 19, 2022   |  Thomas C. Crawford, MD, FACC

Journal Scan

What is the association of QT interval on

electrocardiogram with ventricular arrhythmic complications
in patients hospitalized with apical ballooning Takotsubo
syndrome?
Clinical Topics: Acute Coronary Syndromes, Arrhythmias
and Clinical EP, Congenital Heart Disease and Pediatric
Cardiology, Heart Failure and Cardiomyopathies,
Implantable Devices, Genetic Arrhythmic Conditions,
SCD/Ventricular Arrhythmias, Atrial
Fibrillation/Supraventricular Arrhythmias, Congenital Heart
Disease, CHD and Pediatrics and Arrhythmias, CHD and
Pediatrics and Quality Improvement, Acute Heart Failure
Keywords: Acute Coronary Syndrome, Arrhythmias, Cardiac,
Cardiomyopathies, Electrocardiography, Heart Failure, Inpatients,
Long QT Syndrome, Risk, Stroke, Stroke Volume, Takotsubo
Cardiomyopathy, Vascular Diseases, Ventricular Function, Left
Pill-in-the-Pocket Antiarrhythmic Drug for Atrial Fibrillation

Dec 19, 2022   |  Thomas C. Crawford, MD, FACC

Journal Scan

What is the real-world, contemporary use of the Editors'

pill-in-the-pocket approach, including the setting Pick
of initiation and incidence of adverse events?
Clinical Topics: Anticoagulation Management, Arrhythmias
and Clinical EP, Anticoagulation Management and Atrial
Fibrillation, Implantable Devices, EP Basic Science,
SCD/Ventricular Arrhythmias, Atrial
Fibrillation/Supraventricular Arrhythmias
Keywords: Anti-Arrhythmia Agents, Anticoagulants, Arrhythmias,
Cardiac, Atrial Fibrillation, Atrial Flutter, Bradycardia, Electric
Countershock, Flecainide, Hypotension, Pacemaker, Artificial,
Propafenone, Syncope

Re-Entry Vulnerability Index Mapping to Guide Ablation in Post-MI VT Patients

Dec 02, 2022   |  Thomas C. Crawford, MD, FACC

Journal Scan

Does re-entry vulnerability index (RVI) mapping

help to identify relevant activation pathways in patient-
specific computational models of post-myocardial infarction
ventricular tachycardias (post-MI VTs)?
Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular
Care Team, Heart Failure and Cardiomyopathies,
Noninvasive Imaging, Prevention, Implantable Devices, EP
Basic Science, SCD/Ventricular Arrhythmias, Atrial
Fibrillation/Supraventricular Arrhythmias, Acute Heart
Failure, Magnetic Resonance Imaging
Keywords: Ablation Techniques, Arrhythmias, Cardiac, Cardiac
Complexes, Premature, Computer Simulation, Diagnostic Imaging,
Electrophysiology, Heart Failure, Magnetic Resonance Imaging,
Myocardial Infarction, Radiofrequency Ablation, Secondary
Prevention, Tachycardia, Ventricular

SGLT2 Inhibitors and Outcomes After Ablation for Atrial Fibrillation

Nov 23, 2022   |  Thomas C. Crawford, MD, FACC
Journal Scan

What are the effects of sodium-glucose

cotransporter 2 inhibitors (SGLT2i) on atrial fibrillation (AF)
after catheter ablation?
Clinical Topics: Arrhythmias and Clinical EP, Heart Failure
and Cardiomyopathies, Prevention, Implantable Devices,
SCD/Ventricular Arrhythmias, Atrial
Fibrillation/Supraventricular Arrhythmias, Acute Heart
Failure, Heart Failure and Cardiac Biomarkers,
Hypertension
Keywords: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial
Remodeling, Catheter Ablation, Creatinine, Diabetes Mellitus, Type 2,
Dipeptidyl-Peptidase IV Inhibitors, Heart Failure, Hypertension,
Natriuretic Peptide, Brain, Obesity, Primary Prevention, Pulmonary
Veins, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Stroke
Volume, Tachycardia, Ventricular Function, Left
Predictors of Treatment Response in Cardiac Sarcoidosis

Nov 10, 2022   |  Thomas C. Crawford, MD, FACC

Journal Scan

What is the effect of immunosuppressive therapy

and biopsy status to achieve complete treatment response,
partial treatment response, or no response on myocardial
fluorodeoxyglucose (FDG)–positron emission tomography
(PET)/computed tomograph...
Clinical Topics: Arrhythmias and Clinical EP, Cardio-
Oncology, Heart Failure and Cardiomyopathies, Invasive
Cardiovascular Angiography and Intervention, Noninvasive
Imaging, Implantable Devices, SCD/Ventricular
Arrhythmias, Atrial Fibrillation/Supraventricular
Arrhythmias, Acute Heart Failure, Interventions and
Imaging, Computed Tomography, Nuclear Imaging
Keywords: Arrhythmias, Cardiac, Biopsy, Cardiotoxicity, Diagnostic
Imaging, Fluorodeoxyglucose F18, Heart Failure, Immunosuppression,
Positron Emission Tomography Computed Tomography, Prednisone,
Sarcoidosis, Tomography, X-Ray Computed, Treatment Outcome,
Ventricular Function, Left
 Left Bundle Branch Area Pacing Outcomes

Nov 09, 2022   |  Thomas C. Crawford, MD, FACC

Journal Scan

What are the outcomes of permanent transseptal

left bundle branch area pacing (LBBAP)?
Clinical Topics: Arrhythmias and Clinical EP, Geriatric
Cardiology, Heart Failure and Cardiomyopathies,
Implantable Devices, EP Basic Science, SCD/Ventricular
Arrhythmias, Atrial Fibrillation/Supraventricular
Arrhythmias, Acute Heart Failure
Keywords: Arrhythmias, Cardiac, Bradycardia, Bundle-Branch
Block, Geriatrics, Heart Failure, Heart Ventricles, Outcome
Assessment, Health Care, Pacemaker, Artificial

MORE

© 2022 American College of Cardiology Foundation. All rights reserved.